It’s time to talk COVID, something I’ve been avoiding because frankly, it seems like COVID-19 is over talked. However, with variants of concern turning up in positive tests within Manitoba, even within Prairie Mountain Health, there are a couple of things to know.
For one thing, all we seem to hear from official channels are warnings, sickness and death statistics, vaccine info and enforcement; never anything about possible treatment for those who have come down with the virus or what kind of things we can do to help our own body to handle the coronavirus.
“‘Given the way that SARS-CoV-2 is mutating and the continued global impact of COVID-19, it appears likely that it will be critical to have access to therapeutic options both now and beyond the pandemic,’ said Mikael Dolsten, Pfizer’s Chief Scientific Officer, in a statement.” This was a report by Robert Langreth, March 23 in a publication called Bloomberg.
There are treatments being approved in other nations. One in particular is cheap and available, sort of. Farmers are going to be surprised, if they haven’t already heard: it’s ivermectin. That’s right, ivomec has been approved by a European nation. “The Slovakia Republic’s Minister of Health has formerly (sic) registered Ivermectin as an approved prophylaxis and treatment for SARS-CoV-2, the virus behind COVID-19.” This news is recorded by a health news site, TrialSite News, who says the drug had been in use “on a compassionate basis over the past half year.”
Furthermore, a researcher from the University of Toronto, originally from Slovakia, biochemist Ondrej Halgas was interviewed by TriaSsite. He has been following the use of ivermectin and told of a group of physicians in Germany where ivermectin was used, not as a trial, but an actual treatment of about 100 COVID stricken nursing home residents. The use of the antiparasitic drug was noted to reduce mortality of 25 – 30 per cent, down to five per cent.
On Monday, during a press conference, I asked Dr. Brent Roussin what Manitoba health authorities knew of the ivermectin studies. There have been studies done around the world and as well as meta-analysis. Roussin responded that this was not the purview of public health – his domain. But he added that on the treatment side, new information was always being reviewed.
While some 87% of US national coverage of COVID-19 is negative, according to an article in the New York Times, March 24, internationally the average is between 40 and 60 per cent negative.
North American mainstream journalism is not picking up on ivermectin studies, for example. But you can discover this news, as I did. www.youtube.com/watch?v=pDNudfR9Iuk
So, in the midst of a pandemic, the Food and Drug (FDA) regulator in the US seems to have given Ivermectin a black mark regarding off-label use even under doctor discretion. Mainstream news services have picked up and run with that, even though the National Institutes of Health say Ivermectin is notably safe to use.
Well, it’s an interesting story and the video sheds light on how a super cheap drug is being regarded. I wonder how Pfizer’s therapeutic product trial will be regarded? Surely this won’t be about the money, will it?
